Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia

Journal of Lipid Research

Volumn 39, Issue 5, 1998, Pages 1071-1078

  Bruce, Can ^a   Sharp, Dan S ^b   Tall, Alan R ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cholesteryl ester transfer protein; Coronary heart disease; High density lipoproteins; Hypertryiglyceridemia; Lipid transfer protein

Indexed keywords

AMINO ACID; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HUMAN; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MALE; PREVALENCE; PRIORITY JOURNAL;

AMINO ACIDS; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; CORONARY DISEASE; GENE FREQUENCY; GLYCOPROTEINS; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS, HDL; MALE; POLYMORPHISM, GENETIC; PREVALENCE;

EID: 0031942155     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Tall, A. 1995. Plasma lipid transfer proteins. Annu. Rev. Biochem. 64: 235-257.
2. Bruce, C., and A. R. Tall. 1995. Cholesteryl ester transfer protein, reverse cholesterol transport and atherosclerosis. Curr. Opin. Lipidol. 6: 306-311.
3. Mann, C. J., F. T. Yen, A. M. Grant, and B. E. Bihain. 1991. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J. Clin. Invest. 88: 2059-2066.
4. Rhoads, G. G., C. L. Gulbi andsen, and A. Kagan. 1976. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N. Engl. J. Med. 294: 293-298.
5. Miller, N. E., D. S. Thelle, O. H. Forde, and O. D. Mjos. 1977. The Tromso Heart Study: high density lipoprotein and coronary heart disease: a prospective case-control study. Lancet. 1: 965-968.
6. Gordon T., W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber. 1977. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Heart Study. Am. J. Med. 62:707-714.
7. Zhong, S., D. S. Sharp, J. S. Grove, C. Bruce, K. Yano, J. D. Curb, and A. R. Tall. 1996. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J. Clin. Invest. 97: 2917-2923.
8. Takahashi, K., X-C. Jiang, N. Sakai, S. Yamashita, K. Hirano, H. Bujo, H. Yamazaki, J. Kusunoki, T. Miura, P. Russie, Y. Matsuzawa, Y. Saito, and A. Tall. 1993. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J. Clin Invest. 92: 2060-2064.
9. Brown, M. L., A. Inazu, C. B. Hesler, L. B. Abellon, C. Mann, M. E. Whitlock, Y. L. Marcel, R. W. Milne, J. Koizumi, H. Mabuchi, R. Takeda, and A. R. Tall. 1989. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature (London) 342: 448-451.
10. Inazu, A., X-C. Jiang, T. Haraki, K. Yagi, N. Kamon, J. Koizumi, H. Mabuchi, R. Takeda, K. Takata, Y. Moriyama, M. Doi, and A. R. Tall. 1994. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J. Clin. Invest. 94: 1872-1882.
11. Arai, T., S. Yamashita, N. Sakai, K. Hirano, S. Okada, M. Ishigami, T. Maruyama, M. Yamane, H. Kobayashi, S. Nozaki, T. Funahashi, K. Kameda-Takemura, N. Nakajima, and Y. Matsuzawa. 1996. A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects. J Lipid Res. 37: 2145-2154.
12. Sakai, N., S. Santamarina-Fojo, S. Yamashita, Y. Matsuzawa, and H. B. Brewer, Jr. 1996. Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection. J Lipid Res. 37: 2065-2073.
13. Gotoda T., M. Kinoshita, H. Shimano, K. Harada, M. Shimada, J. Ohsuga, T. Teramoto, Y. Yazaki, and N. Yamada. 1993. Cholesteryl ester transfer protein deficiency caused by a nonsense mutation detected in the patient's macrophage mRNA. Biochem. Biophys. Res. Commun. 194: 519-524
14. Cohen, J. C., Z. Wang, S. M. Grundy, M. R. Stoesz, and R. Guerra. 1994. Variation at the hepatic lipase and apolipoprotein AI/CII/ AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J. Clin. Invest. 94:2377-2384.
15. Bu, X., C. H. Warden, Y. R. Xia, C. De Meester, D. L. Puppione, S. Teruya, B. Lokensgard, S. Daneshmand, J. Brown, R. J. Gray, J. I. Rotter, and A. J. Lusis. 1994. Linkage analysis of the genetic determinants of high density lipoprotein concentrations and composition: evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein loci. Hum. Genet. 93: 639-648.
16. Agellon, L. B., E. M. Quinet, T. G. Gillette, D. T. Drayna, M. L. Brown, and A. R. Tall. 1990. Organization of the human cholesteryl ester transfer protein gene. Biochemistry. 29: 1372-1376.
17. Funke H., H. Wiebusch, L. Fuer, S. Muntoni, H. Schulte, and G. Assmann. 1994. Identification of mutations in the cholesterol ester transfer protein in Europeans with elevated high density lipoprotein cholesterol. Circulation. 90 (pt 2): 1-241.(Abstr.)
18. Trombold J. C., R. C. Moellering, Jr., and A. Kagan. 1966. Epidemiological aspects of coronary heart disease and cerebrovascular disease: the Honolulu Heart Program. Hawaii Med J. 25: 231-234.
19. Kuivenhoven, J. A., P. de Knijff, J. M. A. Boer, H. A. Smalheer, G. Botma, J. C. Seidell, J. J. P. Kastelein, and P. H. Pritchard. 1997. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 17: 560-568.
20. Marcel, Y. L., R. McPherson, M. Hogue, H. Czarneka, Z. Zawadski, P. Weech, M. E. Whitlock, A. R. Tall, and R. W. Milne. 1990. Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipidemic subjects. J. Clin. Invest. 85: 10-17.
21. Fried, L. N., N. O. Borhani, and P. Enright, for the CHS Investigators. 1991. The Cardiovascular Health Study: design and rationale. Ann. Epidemiol. 1: 263-276.
22. Tall, A. R., E. Granot, R. Brocia, I. Tabas, C. Hesler, K. Williams, and M. Denke. 1987. Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. J. Clin. Invest. 79: 1217-1225.
23. Wilcosky, T. C. and L. F. Chanbless. 1985. A comparison of direct adjustment and regression adjustment of epidemiologic measures. J. Chronic Dis. 38: 849-856.
24. Ott, J. 1979. Detection of rare major genes in lipid levels. Hum. Genet. 51:79-91.
25. Hayek, T., N. Azrolan, R. B. Verdery, A. Walsh, T. Chajek-Shaul, L. B. Agellon, A. R. Tall, and J. L. Breslow. 1993. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes and metabolism. Studies in transgenic mice. J. Clin. Invest. 92: 1143-1152.
26. Beamer, L. J., S. F. Carroll, and D. Eisenberg. 1997. Crystal structure of human BPI and two bound phospholipids at 2.4 Ångstrom resolution. Science. 276: 1861-1864
27. Freeman, D. J., C. J. Packard, J. Shepherd, and D. Gaffney. 1990. Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin. Sci. (Colch). 79: 575-581.
28. McPherson, R., S. M. Grundy, R. Guerra, and J. C. Cohen. 1996. Allelic variation in the gene encoding the cholesteryl ester transfer protein is associated with variation in the plasma concentrations of cholesteryl ester transfer protein. J. Lipid Res. 37: 1743-1748.
29. Oliveira, H. C. F., R. A. Chouinard, L. B. Agellon, C. Bruce, L. Ma, A. Walsh, J. L. Breslow, and A. R. Tall. 1996. Human cholesteryl ester transfer protein gene proximal promoter contains dietary cholesterol positive responsive elements and mediates expression in small intestine and periphery while predominant liver and spleen expression is controlled by 5′-distal sequences. Cis-acting sequences mapped in transgenic mice. J. Biol. Chem. 271: 31831-31838.
30. Tatò, F., G. L. Vega, A. R. Tall, and S. M. Grundy. 1995. Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 15: 112-120.
31. Föger, B., A. Ritsch, A. Doblinger, H. Wessels, and J. R. Patsch. 1996. Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 16: 1430-1436.
32. Tatò, F., G. L. Vega, and S. M. Grundy. 1997. Determinants of Plasma HDL-cholesterol in hypertriglyceridemic patients: role of cholesterol ester transfer protein and lecithin cholesteryl acyl transferase. Arterioscler. Thromb. Vasc. Biol. 17: 56-63.
33. Murakami, T., S. Michelagnoli, R. Longhi, G. Gianfranceschi, F. Pazzuconi, L. Calabresi, C. R. Sirtori, and G. Franceschini. 1995. Triglycerides are major determinants of cholesterol esterification/ transfer and HDL remodeling in human plasma. Arterioscler. Thromb. Vasc. Biol. 15: 1819-1828.
34. Hayek, T., L. Masucci-Magoulas, X. Jiang, A. Walsh, E. Rubin, J. L. Breslow, and A. R. Tall. 1995. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene J. Clin. Invest. 96: 2071-2074.
35. Masucci-Magoulas, L., I. J. Goldberg, C. L. Bisgaier, H. Serajuddin, O. L. Francone, J. L. Breslow, and A. R. Tall. 1997. A mouse model with features of familial combined hyperlipidemia. Science. 275: 391-394.
36. Marotti, K. R., C. K. Castle, T. P. Boyle, A. H. Lin, R. W. Murray, and G. W. Melchior. 1993. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature. 364: 73-75.
37. Glass, C., R. C. Pittman, D. B. Weinstein, and D. Steinberg. 1983. Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonad. Proc. Natl. Acad. Sci. USA. 80: 5435-5439.